Advisor Group Holdings, Inc. Bausch Health Companies Inc. Transaction History

Advisor Group Holdings, Inc.

$67.1 Billion
Q3 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 40,426 shares of BHC stock, worth $253,875. This represents 0.0% of its overall portfolio holdings.

Number of Shares

40,426

Previous 7,825 416.63%

Holding current value

$253,875

Previous $52,000 400.0%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$5.71 - $8.34 $186,151 - $271,892	32,601 Added 416.63%	40,426 $260,000
Q2 2025 Sep 04, 2025	SELL	$4.32 - $6.66 $1,464 - $2,257	-339 Reduced 4.15%	7,825 $52,000
Q2 2025 Aug 13, 2025	BUY	$4.32 - $6.66 $2,198 - $3,389	509 Added 6.65%	8,164 $54,000
Q1 2025 May 12, 2025	SELL	$6.16 - $7.94 $1,989 - $2,564	-323 Reduced 4.05%	7,655 $49,000
Q4 2024 Jun 06, 2025	BUY	$7.34 - $9.78 $7,699 - $10,259	1,049 Added 13.7%	8,704 $70,000

Q4 2024 Feb 07, 2025	SELL	$7.34 - $9.78 $6,583 - $8,772	-897 Reduced 10.11%	7,978 $64,000
Q3 2024 Nov 13, 2024	SELL	$5.22 - $8.26 $17,356 - $27,464	-3,325 Reduced 27.25%	8,875 $72,000
Q2 2024 Aug 13, 2024	SELL	$6.1 - $10.41 $37,740 - $64,406	-6,187 Reduced 33.65%	12,200 $85,000
Q1 2024 May 10, 2024	SELL	$7.77 - $10.61 $6,410 - $8,753	-825 Reduced 4.29%	18,387 $195,000
Q4 2023 Feb 12, 2024	SELL	$6.53 - $8.23 $32,996 - $41,586	-5,053 Reduced 20.82%	19,212 $154,000
Q3 2023 Nov 13, 2023	SELL	$7.69 - $9.71 $57,198 - $72,222	-7,438 Reduced 23.46%	24,265 $199,000
Q2 2023 Aug 21, 2023	SELL	$5.72 - $8.8 $4,564 - $7,022	-798 Reduced 2.46%	31,703 $253,000
Q2 2023 Aug 10, 2023	SELL	$5.72 - $8.8 $16,416 - $25,256	-2,870 Reduced 8.11%	32,501 $260,000
Q1 2023 May 12, 2023	SELL	$6.28 - $9.85 $53,656 - $84,158	-8,544 Reduced 19.46%	35,371 $286,000
Q4 2022 Feb 10, 2023	SELL	$6.09 - $7.93 $59,194 - $77,079	-9,720 Reduced 18.12%	43,915 $275,000
Q3 2022 Nov 14, 2022	SELL	$4.58 - $9.21 $11,853 - $23,835	-2,588 Reduced 4.6%	53,635 $369,000
Q2 2022 Aug 10, 2022	SELL	$7.06 - $23.63 $243,534 - $815,116	-34,495 Reduced 38.02%	56,223 $470,000
Q1 2022 May 04, 2022	BUY	$21.6 - $27.79 $837,453 - $1.08 Million	38,771 Added 74.64%	90,718 $2.18 Million
Q3 2021 Nov 05, 2021	BUY	$25.04 - $30.06 $262,995 - $315,720	10,503 Added 25.34%	51,947 $1.45 Million
Q2 2021 Aug 02, 2021	BUY	$27.43 - $32.7 $33,848 - $40,351	1,234 Added 3.07%	41,444 $1.22 Million
Q1 2021 May 13, 2021	SELL	$21.37 - $34.38 $194,637 - $313,133	-9,108 Reduced 18.47%	40,210 $1.28 Million
Q4 2020 Feb 10, 2021	BUY	$15.31 - $21.12 $121,637 - $167,798	7,945 Added 19.2%	49,318 $1.03 Million
Q3 2020 Nov 12, 2020	SELL	$14.88 - $20.13 $5,565 - $7,528	-374 Reduced 0.9%	41,373 $648,000
Q2 2020 Aug 14, 2020	BUY	$13.31 - $20.51 $90,188 - $138,975	6,776 Added 19.38%	41,747 $765,000
Q1 2020 May 18, 2020	BUY	$12.98 - $30.25 $453,923 - $1.06 Million	34,971 New	34,971 $540,000

Others Institutions Holding BHC

# of Institutions

262

Shares Held

207M

Call Options Held

2.54M

Put Options Held

6.46M

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.27B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Bausch Health Companies Inc. Transaction History